Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2018 10:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET

RALEIGH, N.C., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation...
January 31, 2018 07:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018

RALEIGH, N.C., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation...
January 30, 2018 11:30 ET | Source: Innovate Biopharmaceuticals, Inc

CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT) please note that the stock symbol for...
January 30, 2018 06:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Successful Merger Completion

Completion of Merger with Monster Digital, Inc.Shares of combined company will begin trading on Nasdaq with new ticker INNT and will reflect a 1 for 10 reverse split on Wednesday, January 31,...
December 28, 2017 09:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability

RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
September 06, 2017 17:06 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation

RALEIGH, N.C., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
July 12, 2017 07:07 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis Indication

RALEIGH, N.C., July 12, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
June 06, 2017 08:07 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention

RALEIGH, N.C., June 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, a leader in developing innovative therapies for autoimmune and inflammatory diseases, will present on its phase 3 drug...